A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.

Clamp, A R; Schöffski, P; Valle, J W; Wilson, R H; Marreaud, S; Govaerts, A-S; Debois, M; Lacombe, D; Twelves, C; Chick, J; Jayson, G C

Clamp, A R; Schöffski, P; Valle, J W; Wilson, R H; Marreaud, S; Govaerts, A-S; Debois, M; Lacombe, D; Twelves, C; Chick, J; Jayson, G C.

Affiliation

Clamp AR; Cancer Research UK and University of Manchester Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester, M20 4BX, UK. Andrew.Clamp@christie.nhs.uk

Cancer Chemother Pharmacol ; 61(4): 579-85, 2008 Apr.

Article in En | MEDLINE | ID: mdl-17520255

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidylate Synthase / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2008 Document type: Article Affiliation country: Reino Unido Country of publication: Alemania

Search on Google

Add to My VHL

XML

PubMed Links